310441
Lead(II) chromate
ACS reagent, ≥98.0%
Sign Into View Organizational & Contract Pricing
Select a Size
About This Item
Linear Formula:
PbCrO4
CAS Number:
Molecular Weight:
323.19
EC Number:
MDL number:
UNSPSC Code:
12352300
grade
ACS reagent
Assay
≥98.0%
impurities
≤0.01% C compounds
≤0.15% solubles
SMILES string
[PbH2++].[O-][Cr]([O-])(=O)=O
InChI
1S/Cr.4O.Pb/q;;;2*-1;+2
InChI key
MOUPNEIJQCETIW-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Aquatic Acute 1 - Aquatic Chronic 2 - Carc. 1A - Repr. 1A - STOT RE 2
Storage Class Code
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Stephen S Leonard et al.
Molecular and cellular biochemistry, 255(1-2), 171-179 (2004-02-20)
Exposure to certain particulate hexavalent chromium [Cr(VI)] compounds, such as lead chromate (PbCrO4), has been associated with lung cancer and respiratory tract toxicity. Previous studies indicate that the solubility of Cr(VI)-compounds is an important factor in Cr(VI)-induced carcinogenesis. The present
Role of the Fancg gene in protecting cells from particulate chromate-induced chromosome instability.
Laura C Savery et al.
Mutation research, 626(1-2), 120-127 (2006-11-14)
Particulate hexavalent chromium (Cr(VI)) is a known human lung carcinogen. Cr(VI)-induced tumors exhibit chromosome instability (CIN), but the mechanisms underlying these effects are unknown. We investigated a possible role for the Fanconi anemia (FA) pathway in particulate Cr(VI)-induced chromosomal damage
Amie L Holmes et al.
Toxicology and applied pharmacology, 203(2), 167-176 (2005-02-16)
Hexavalent chromium (Cr (VI)) compounds are established human lung carcinogens. Solubility plays a key role in Cr (VI) carcinogenicity, with the most potent carcinogens being water-insoluble or 'particulate'. Lead chromate is used as the prototypical particulate Cr (VI) compound since
Megan M Stackpole et al.
Mutation research, 625(1-2), 145-154 (2007-07-31)
Particulate hexavalent chromium [Cr(VI)] compounds are well-established human carcinogens. Cr(VI)-induced tumors are characterized by chromosomal instability (CIN); however, the mechanisms of this effect are unknown. We investigated the hypothesis that homologous recombination (HR) repair of DNA double-strand breaks protect cells
Sandra S Wise et al.
Mutation research, 560(1), 79-89 (2004-04-22)
Hexavalent chromium (Cr(VI)) is a well-established human lung carcinogen with potentially widespread exposure. Solubility is a key factor in the carcinogenicity of Cr(VI), with the water-insoluble or 'particulate' compounds being the more potent carcinogens. Studies have indicated that the component
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service